Skip to main content

and
  1. No Access

    Article

    Chemotherapy-induced aseptic thrombophlebitis with an air bubble in the thrombus

    Osamu Imataki, Haruyuki Fujita, Makiko Uemura in International Journal of Hematology (2024)

  2. No Access

    Article

    Comprehensive procedure for injecting Evusheld® for hematological diseases in a single institute

    Tixagevimab and cilgavimab (EVA, Evusheld®), monoclonal antibody combination treatments, consisted of two neutralizing antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). EVA showe...

    Osamu Imataki, Shunsuke Yoshida, Tomoya Ishida, Makiko Uemura in Annals of Hematology (2024)

  3. Article

    Open Access

    Potential factors for and the prognostic impact of ascites after allogeneic hematopoietic stem cell transplantation

    Ascites is sometimes detected after allogeneic hematopoietic stem cell transplantation (allo-HSCT); however, since limited information is currently available, its clinical meaning remains unclear. Therefore, w...

    Hiroyuki Kubo, Osamu Imataki, Tetsuya Fukumoto, Yui Kawanaka in Scientific Reports (2023)

  4. Article

    Open Access

    Repeated spontaneous remission of acute myeloid leukemia in response to various infections: a case report

    Acute myeloid leukemia (AML) is a progressive hematological malignancy that can be fatal when left untreated. However, spontaneous remission is rarely observed in the presence of infectious diseases.

    Osamu Imataki, Tomoya Ishida, Jun-ichiro Kida, Makiko Uemura in BMC Infectious Diseases (2023)

  5. Article

    Correction to: Histologic transformation of t(11;18)-positive MALT lymphoma presented with aberrant T-cell marker expression

    M. Nishikori receives honoraria from Eisai and funding from Eisai and Sumitomo Dainippon Pharmaceutical.

    Naoki Tamura, Hirona Maeda, Momoko Nishikori in International Journal of Hematology (2020)

  6. No Access

    Article

    Histologic transformation of t(11;18)-positive MALT lymphoma presented with aberrant T-cell marker expression

    Mucosa-associated lymphoid tissue (MALT) lymphoma with t(11;18)(q21;q21), resulting in an API2-MALT1 fusion transcript, is reported to rarely transform into aggressive lymphoma. Here, we report the clinical cours...

    Naoki Tamura, Hirona Maeda, Momoko Nishikori in International Journal of Hematology (2020)

  7. No Access

    Article

    Refractory IGκ/IRF4-positive DLBCL with CDKN2A/2B deletion

    Kazuhisa Chonabayashi, Shigeki Tamori, Masafumi Taniwaki in Annals of Hematology (2014)

  8. No Access

    Article

    Durable hematological response and improvement of nephrotic syndrome on thalidomide therapy in a patient with refractory light chain deposition disease

    Light chain deposition disease (LCDD) is a rare disease for which an optimal treatment is not yet available. Here, we report the clinical course of a 32-year-old woman with LCDD who was successfully treated wi...

    Haruyuki Fujita, Masakatsu Hishizawa in International Journal of Hematology (2011)

  9. No Access

    Article

    A case of HIV-associated lymphoproliferative disease that was successfully treated with highly active antiretroviral therapy

    We report a case of a 41-year-old male with human immunodeficiency virus (HIV)-associated lymphoproliferative disease (LPD) who was successfully treated with highly active antiretroviral therapy (HAART). He pr...

    Haruyuki Fujita, Momoko Nishikori in International Journal of Hematology (2010)

  10. No Access

    Article

    Multiple Granulocytic Sarcomas in Essential Thrombocythemia

    A 59-year-old woman was diagnosed with essential thrombocythemia in 1988 and had been treated with hydroxyurea, mitobronitol, busulfan, and ranimustine, in that order. Hepatosplenomegaly, low-grade fever, and ...

    Yasuhiro Tanaka, Yuya Nagai, Minako Mori in International Journal of Hematology (2006)

  11. No Access

    Article

    Multiple Extranodal Tumors in µ-Heavy Chain Disease

    Akinori Maeda, Minako Mori, Satoko Torii, Yuya Nagai in International Journal of Hematology (2006)

  12. No Access

    Article

    Chronic Eosinophilic Leukemia with the FIP1L1-PDGFR± Fusion Gene in a Patient with a History of Combination Chemotherapy

    Hypereosinophilic syndrome (HES) was diagnosed in December 2000 in a 43-year-old man on the basis of persistent eosinophilia (11.7 x 109/L) and a normal karyotype of the bone marrow cells. He had developed int...

    Yasuhiro Tanaka, Masayuki Kurata, Katsuhiro Togami in International Journal of Hematology (2006)